NEO-220

N/A

Report date: 2026/01/27 17:57:36
NME

Base Information

Drug NameNEO-220
Drug Alias NameTMZ POH Linoleic acidTemozolomide-POH-linoleic acidTMZ-POH-linoleic acid
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsDNA synthesis inhibitorsAlkylating agents +[4] 
TargetsGTPase Ras
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeonc Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeonc Technologies Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A